Ophthalmology PACS Market Size, Share & Trends Analysis Report By Type (Integrated, Standalone), By End Use (Hospitals, Specialty Clinics), By Delivery Mode (Cloud-based, On-Premise), And Segment Forecasts, 2018 - 2025

Industry Insights

The global ophthalmology PACS market size was valued at USD 103.14 million in 2017 and is expected to witness a CAGR of 6.5% during the forecast period. Key drivers attributing to the market growth include increasing adoption of teleophthalmology solutions due to lack of skilled ophthalmologists and optometrists. Moreover, significant growth in Information Technology (IT) and its rising impact on the ophthalmology practices are anticipated to drive the market.

Furthermore, high prevalence of diabetes and diabetic eye diseases, such as Diabetic Macular Edema (DME), diabetic retinopathy, cataract, and glaucoma, is likely to boost market. For instance, as per a study conducted by the International Diabetes Federation (IDF), in 2017, around 3.27 million cases of diabetes were diagnosed in France.

Increasing ophthalmic disease burden, high unmet medical needs in emerging economies, and increased public and private healthcare expenditure to improve the vision care practices will further fuel the demand. Moreover, rising demand for early and accurate detection methods is expected to propel the market growth in the coming years.

Electronic Health Record (EHR) and Electronic Medical Record (EMR) systems provide complete and accurate information to healthcare service providers, thereby helping in improving the diagnosis while reducing medical errors. Thus, government organizations taking initiatives to encourage the adoption of EHR and EMR will further fuel usage of ophthalmic PACS systems.

Type Insights

Integrated systems segment held the major share of the global ophthalmology PACS market in 2017. These systems integrate clinical applications, such as data integration, functional integration, context integration, and presentation integration. Thus, the systems used with diagnostic device provides an ability to physicians to review the patient reports and diagnosis outcomes from anywhere and anytime.

Technological and product advancements in the segment will further boost growth in the near future. For instance, in November 2015, Heidelberg Engineering launched SPECTRALIS glaucoma and retina imaging platform. Features offered by integrated systems, such as easy interpretability, good user interface, data portability, security, cost-effectiveness, and ease of deployment, will further fuel demand for this segment in near future.

Delivery Mode Insights

The cloud-based system segment is anticipated to register the highest CAGR during the forecast period. The cloud-based systems provide flexibility to the physicians for accessing medical records at any time and from anywhere. Thus, healthcare providers worldwide are now using these systems for distributing images, delivering reports, imaging studies, providing redundant data storage.

In addition, companies are focusing on merger and acquisition activities to deliver novel product line. For instance, in April 2018, Topcon Healthcare Solutions, a subsidiary of Topcon Corporation has acquired KIDE Systems, a Finland-based company. Through this acquisition, Topcon added KIDE OPTOFLOW, a cloud-based ophthalmic solution to its portfolio.

End-use Insights

Collaborations between major market players and hospital and clinics to deliver advanced PACS solutions and services will fuel the adoption in the hospitals. For instance, in April 2016, Sectra, an international medical imaging IT company, and ProMedica, a U.S.-based hospital chain, entered into a six-year contract to deliver PACS services to ProMedica.

Moreover, government initiatives to increase adoption of systems in hospitals will further propel segment growth. For instance, according to an independent study published in JAMA Ophthalmology, adoption of EHR has nearly doubled from 19% in 2006 to 72.1% in 2016 in the U.S.

Regional Insights

North America led the overall market in 2017, owing to the presence of well-developed healthcare infrastructure, government funding, and high public and private expenditure in the healthcare sector. Rising ophthalmic disease burden is expected to fuel the region’s growth further. According to a study conducted by the National Institutes of Health (NIH), in 2014, the annual economic burden of eye disease, vision loss, and other disorders was around USD 139 billion in the U.S.

Asia Pacific is expected to be the fastest-growing region over the forecast period. The healthcare sector in this region is expected to witness lucrative growth owing to high budget allocation to improve healthcare outcomes, reduce disease burden, and to address the high unmet clinical needs. Moreover, government initiatives encouraging the usage of EHR and EMR will further fuel the market growth. For instance, ‘Electronic Health Records Standards and Guidelines’ set by the Indian government and The Digital India Healthcare’ initiatives have uplifted the adoption of EHR in the country.

Ophthalmology PACS Market Share Insights

Carl Zeiss Meditec AG; Topcon Corp.; Merge Healthcare, Inc. (IBM Watson Health); Heidelberg Engineering GmbH; Visbion Ltd.; Sonomed Escalon; EyePACS, LLC; VersaSuite; and ScImage, Inc. are some of the key companies in the market. Most of them focus on M&A to deliver innovative product portfolio. For instance, in August 2015, IBM Corp. acquired Merge Healthcare. Through the acquisition, IBM combined Merge Healthcare’s medical imaging management platform with Watson’s cloud-based healthcare computing system to deliver advanced portfolio in the market.

Moreover, technological advancements and consistent system upgrades through R&D are other strategies adopted by these companies. For instance, in March 2016, ScImage Inc. launched PicomSentry application that enables users to utilize PICOM365 PACS with plug and play convenience. PicomSentry enables safe transfer and acquisition of DICOM and non-DICOM reports, HL7 messaging, and patient studies between Picom365 Cloud PACS.

Report Scope

Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global ophthalmology PACS market report on the basis of type, delivery mode, end use, and region:

• Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Standalone

  • Integrated

• Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)

  • On-Premise System

  • Cloud-Based System

• End-use Outlook (Revenue, USD Million, 2014 - 2025)

  • Hospital

  • Specialty Clinics

  • Others

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

  • Latin America

    • Mexico

    • Brazil

  • Middle East & Africa

    • South Africa